RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Anixa Biosciences ROCE 2024

Anixa Biosciences ROCE

-0.45

Anixa Biosciences Dividend yield

Ticker

ANIX

ISIN

US03528H1095

WKN

A2N6ZF

In 2024, Anixa Biosciences's return on capital employed (ROCE) was -0.45, a -6.72% increase from the -0.48 ROCE in the previous year.

Anixa Biosciences Aktienanalyse

What does Anixa Biosciences do?

Anixa Biosciences Inc is a biotechnology company focused on the development and commercialization of cancer therapeutics. The company is headquartered in San Jose, California and was founded in 1982. The history of Anixa Biosciences Inc began as a subsidiary of VaxGen Inc, a now dissolved biotechnology company. Originally, Anixa focused on the development of vaccines for infectious diseases before shifting its focus to cancer therapeutics. Since 2016, Anixa Biosciences Inc has made rapid progress, particularly in the field of cancer immunotherapy. The company has formed several partnerships with other major pharmaceutical companies such as Cleveland Clinic and OntoChem to accelerate the development of treatments for various types of cancer. Anixa Biosciences Inc's business model is based on the development and commercialization of patented cancer therapeutics. Anixa has specialized in the development of immunotherapeutics based on its own proprietary technology platform. The company has specialized in three areas: cancer detection, immunotherapy, and antibody production. In cancer detection, the company is working on the development of diagnostic tools that enable doctors to detect and treat cancer at an early stage. In the field of immunotherapy, Anixa has developed various therapeutics that stimulate the body's immune system to attack and destroy cancer cells. The company has specifically developed immunotherapeutics that specialize in targeted attacks on cancer cells. In antibody production, Anixa focuses on the development of monoclonal antibodies that specifically target tumor cells. These antibodies can be used to identify and isolate cancer cells. Additionally, they can be used as carriers for drugs to provide targeted therapies against tumor cells. Another product of Anixa Biosciences Inc is the CchekTM blood test, which was developed for the detection of breast, ovarian, and prostate cancer. The blood test is based on the discovery of specific biomarkers that can indicate an increased presence of cancer cells in blood samples. In 2019, Anixa announced its entry into the rapidly growing market for in-vitro diagnostics. This market includes the development and commercialization of diagnostic tools used for disease identification and monitoring disease progression. Anixa plans to expand its expertise in cancer diagnostics to other disease areas such as cardiovascular diseases and neurological diseases. Overall, Anixa Biosciences Inc has a diverse portfolio of products specializing in the development of cancer therapeutics, diagnostic tools, and immune competence. The company works closely with established research and development companies to enhance its technologies and create new products. Anixa positions itself as an innovative and future-oriented company in the biotechnology industry. Anixa Biosciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Anixa Biosciences's Return on Capital Employed (ROCE)

Anixa Biosciences's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Anixa Biosciences's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Anixa Biosciences's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Anixa Biosciences’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Anixa Biosciences Stock

What is the ROCE (Return on Capital Employed) of Anixa Biosciences this year?

The ROCE of Anixa Biosciences is -0.45 undefined this year.

How has the ROCE (Return on Capital Employed) of Anixa Biosciences developed compared to the previous year?

The ROCE of Anixa Biosciences has increased by -6.72% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Anixa Biosciences?

A high Return on Capital Employed (ROCE) indicates that Anixa Biosciences has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Anixa Biosciences?

A low ROCE (Return on Capital Employed) can indicate that Anixa Biosciences has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Anixa Biosciences impact the company?

An increase in the ROCE of Anixa Biosciences can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Anixa Biosciences affect the company?

A decrease in ROCE of Anixa Biosciences can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Anixa Biosciences?

Some factors that can affect Anixa Biosciences's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Anixa Biosciences so important for investors?

The ROCE of Anixa Biosciences is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Anixa Biosciences take to improve the ROCE?

To improve the ROCE, Anixa Biosciences can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Anixa Biosciences pay?

Over the past 12 months, Anixa Biosciences paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Anixa Biosciences is expected to pay a dividend of 0 USD.

What is the dividend yield of Anixa Biosciences?

The current dividend yield of Anixa Biosciences is .

When does Anixa Biosciences pay dividends?

Anixa Biosciences pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Anixa Biosciences?

Anixa Biosciences paid dividends every year for the past 0 years.

What is the dividend of Anixa Biosciences?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Anixa Biosciences located?

Anixa Biosciences is assigned to the 'Health' sector.

Wann musste ich die Aktien von Anixa Biosciences kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Anixa Biosciences from 5/3/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/3/2024.

When did Anixa Biosciences pay the last dividend?

The last dividend was paid out on 5/3/2024.

What was the dividend of Anixa Biosciences in the year 2023?

In the year 2023, Anixa Biosciences distributed 0 USD as dividends.

In which currency does Anixa Biosciences pay out the dividend?

The dividends of Anixa Biosciences are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Anixa Biosciences

Our stock analysis for Anixa Biosciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Anixa Biosciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.